COVID-19 Vaccine Effectiveness at a Referral Hospital in Northern Peru: A Retrospective Cohort Study

COVID-19 vaccines have achieved a significant reduction in mortality, yet objective estimates are needed in specific settings. We aimed to determine the effectiveness of COVID-19 vaccination at a referral hospital in Lambayeque, Peru. We conducted a retrospective cohort study from February to Septem...

Full description

Bibliographic Details
Main Authors: Mario J. Valladares-Garrido, Sandra Zeña-Ñañez, C. Ichiro Peralta, Jacqueline B. Puicón-Suárez, Cristian Díaz-Vélez, Virgilio E. Failoc-Rojas
Format: Article
Language:English
Published: MDPI AG 2022-05-01
Series:Vaccines
Subjects:
Online Access:https://www.mdpi.com/2076-393X/10/5/812
_version_ 1797494781971005440
author Mario J. Valladares-Garrido
Sandra Zeña-Ñañez
C. Ichiro Peralta
Jacqueline B. Puicón-Suárez
Cristian Díaz-Vélez
Virgilio E. Failoc-Rojas
author_facet Mario J. Valladares-Garrido
Sandra Zeña-Ñañez
C. Ichiro Peralta
Jacqueline B. Puicón-Suárez
Cristian Díaz-Vélez
Virgilio E. Failoc-Rojas
author_sort Mario J. Valladares-Garrido
collection DOAJ
description COVID-19 vaccines have achieved a significant reduction in mortality, yet objective estimates are needed in specific settings. We aimed to determine the effectiveness of COVID-19 vaccination at a referral hospital in Lambayeque, Peru. We conducted a retrospective cohort study from February to September 2021. We included hospitalized patients with COVID-19, whose data were stored in NotiWeb, a patient data system of the Peruvian Ministry of Health. We applied a propensity score-weighting method according to baseline characteristics of patients, and estimated hazard ratios (HR) using Cox regression models. Of 1553 participants, the average age was 55 years (SD: 16.8), 907 (58%) were male, and 592 (38%) deceased at 28-day follow-up. Before hospital admission, 74 (4.8%) had been immunized with at least one vaccine dose. Effectiveness against death in vaccinated patients was 50% at 90-day follow-up (weighted HR 0.50, 95% CI 0.28–0.89). Our results support the effectiveness of COVID-19 vaccination against death and provide information after early immunization in Peru.
first_indexed 2024-03-10T01:39:14Z
format Article
id doaj.art-438101b2653e4010803fadd509703134
institution Directory Open Access Journal
issn 2076-393X
language English
last_indexed 2024-03-10T01:39:14Z
publishDate 2022-05-01
publisher MDPI AG
record_format Article
series Vaccines
spelling doaj.art-438101b2653e4010803fadd5097031342023-11-23T13:27:39ZengMDPI AGVaccines2076-393X2022-05-0110581210.3390/vaccines10050812COVID-19 Vaccine Effectiveness at a Referral Hospital in Northern Peru: A Retrospective Cohort StudyMario J. Valladares-Garrido0Sandra Zeña-Ñañez1C. Ichiro Peralta2Jacqueline B. Puicón-Suárez3Cristian Díaz-Vélez4Virgilio E. Failoc-Rojas5Vicerrectorado de Investigación, Universidad Norbert Wiener, Lima 15046, PeruSchool of Medicine, Universidad Continental, Huancayo 12001, PeruSchool of Medicine, Universidad Nacional Federico Villarreal, Lima 15088, PeruSociedad Científica de Estudiantes de Medicina, Universidad Nacional Pedro Ruiz Gallo, Lambayeque 14013, PeruInstituto de Evaluación de Tecnologías en Salud e Investigación-IETSI, EsSalud, Lima 15072, PeruInstituto de Evaluación de Tecnologías en Salud e Investigación-IETSI, EsSalud, Lima 15072, PeruCOVID-19 vaccines have achieved a significant reduction in mortality, yet objective estimates are needed in specific settings. We aimed to determine the effectiveness of COVID-19 vaccination at a referral hospital in Lambayeque, Peru. We conducted a retrospective cohort study from February to September 2021. We included hospitalized patients with COVID-19, whose data were stored in NotiWeb, a patient data system of the Peruvian Ministry of Health. We applied a propensity score-weighting method according to baseline characteristics of patients, and estimated hazard ratios (HR) using Cox regression models. Of 1553 participants, the average age was 55 years (SD: 16.8), 907 (58%) were male, and 592 (38%) deceased at 28-day follow-up. Before hospital admission, 74 (4.8%) had been immunized with at least one vaccine dose. Effectiveness against death in vaccinated patients was 50% at 90-day follow-up (weighted HR 0.50, 95% CI 0.28–0.89). Our results support the effectiveness of COVID-19 vaccination against death and provide information after early immunization in Peru.https://www.mdpi.com/2076-393X/10/5/812vaccinationCOVID-19mortalityvaccine effectivenessPeru
spellingShingle Mario J. Valladares-Garrido
Sandra Zeña-Ñañez
C. Ichiro Peralta
Jacqueline B. Puicón-Suárez
Cristian Díaz-Vélez
Virgilio E. Failoc-Rojas
COVID-19 Vaccine Effectiveness at a Referral Hospital in Northern Peru: A Retrospective Cohort Study
Vaccines
vaccination
COVID-19
mortality
vaccine effectiveness
Peru
title COVID-19 Vaccine Effectiveness at a Referral Hospital in Northern Peru: A Retrospective Cohort Study
title_full COVID-19 Vaccine Effectiveness at a Referral Hospital in Northern Peru: A Retrospective Cohort Study
title_fullStr COVID-19 Vaccine Effectiveness at a Referral Hospital in Northern Peru: A Retrospective Cohort Study
title_full_unstemmed COVID-19 Vaccine Effectiveness at a Referral Hospital in Northern Peru: A Retrospective Cohort Study
title_short COVID-19 Vaccine Effectiveness at a Referral Hospital in Northern Peru: A Retrospective Cohort Study
title_sort covid 19 vaccine effectiveness at a referral hospital in northern peru a retrospective cohort study
topic vaccination
COVID-19
mortality
vaccine effectiveness
Peru
url https://www.mdpi.com/2076-393X/10/5/812
work_keys_str_mv AT mariojvalladaresgarrido covid19vaccineeffectivenessatareferralhospitalinnorthernperuaretrospectivecohortstudy
AT sandrazenananez covid19vaccineeffectivenessatareferralhospitalinnorthernperuaretrospectivecohortstudy
AT cichiroperalta covid19vaccineeffectivenessatareferralhospitalinnorthernperuaretrospectivecohortstudy
AT jacquelinebpuiconsuarez covid19vaccineeffectivenessatareferralhospitalinnorthernperuaretrospectivecohortstudy
AT cristiandiazvelez covid19vaccineeffectivenessatareferralhospitalinnorthernperuaretrospectivecohortstudy
AT virgilioefailocrojas covid19vaccineeffectivenessatareferralhospitalinnorthernperuaretrospectivecohortstudy